nodes	percent_of_prediction	percent_of_DWPC	metapath
Simvastatin—ABCC2—esophageal cancer	0.348	0.731	CbGaD
Simvastatin—ABCB1—esophageal cancer	0.128	0.269	CbGaD
Simvastatin—ABCC2—Carboplatin—esophageal cancer	0.055	0.18	CbGbCtD
Simvastatin—ABCC2—Cisplatin—esophageal cancer	0.047	0.153	CbGbCtD
Simvastatin—SLCO1A2—Methotrexate—esophageal cancer	0.0368	0.12	CbGbCtD
Simvastatin—SLCO1B1—Methotrexate—esophageal cancer	0.0347	0.113	CbGbCtD
Simvastatin—CYP2C9—Capecitabine—esophageal cancer	0.0314	0.102	CbGbCtD
Simvastatin—ABCC2—Methotrexate—esophageal cancer	0.0305	0.0996	CbGbCtD
Simvastatin—CYP2B6—Cisplatin—esophageal cancer	0.0299	0.0975	CbGbCtD
Simvastatin—CYP2C9—Cisplatin—esophageal cancer	0.0158	0.0515	CbGbCtD
Simvastatin—ABCB1—Cisplatin—esophageal cancer	0.0153	0.05	CbGbCtD
Simvastatin—ABCB1—Methotrexate—esophageal cancer	0.00995	0.0325	CbGbCtD
Simvastatin—ITGB2—epithelium—esophageal cancer	0.00263	0.0985	CbGeAlD
Simvastatin—ITGB2—bronchus—esophageal cancer	0.00259	0.097	CbGeAlD
Simvastatin—Memory loss—Cisplatin—esophageal cancer	0.00222	0.0401	CcSEcCtD
Simvastatin—ITGB2—digestive system—esophageal cancer	0.002	0.075	CbGeAlD
Simvastatin—UGT1A3—digestive system—esophageal cancer	0.00169	0.0631	CbGeAlD
Simvastatin—ITGB2—lung—esophageal cancer	0.00167	0.0626	CbGeAlD
Simvastatin—Lovastatin—ABCC2—esophageal cancer	0.00159	0.366	CrCbGaD
Simvastatin—Pravastatin—ABCC2—esophageal cancer	0.00159	0.366	CrCbGaD
Simvastatin—Sensory disturbance—Capecitabine—esophageal cancer	0.00155	0.028	CcSEcCtD
Simvastatin—Polyneuropathy—Capecitabine—esophageal cancer	0.00148	0.0266	CcSEcCtD
Simvastatin—HMGCR—neck—esophageal cancer	0.00138	0.0517	CbGeAlD
Simvastatin—Cognitive impairment—Methotrexate—esophageal cancer	0.00137	0.0247	CcSEcCtD
Simvastatin—Nodule—Methotrexate—esophageal cancer	0.00122	0.022	CcSEcCtD
Simvastatin—VIIth nerve paralysis—Capecitabine—esophageal cancer	0.00117	0.0212	CcSEcCtD
Simvastatin—ITGB2—lymph node—esophageal cancer	0.00114	0.0428	CbGeAlD
Simvastatin—UGT2B7—digestive system—esophageal cancer	0.000969	0.0362	CbGeAlD
Simvastatin—HMGCR—epithelium—esophageal cancer	0.00094	0.0352	CbGeAlD
Simvastatin—HMGCR—bronchus—esophageal cancer	0.000926	0.0346	CbGeAlD
Simvastatin—HMGCR—smooth muscle tissue—esophageal cancer	0.000906	0.0339	CbGeAlD
Simvastatin—HMGCR—trachea—esophageal cancer	0.000831	0.0311	CbGeAlD
Simvastatin—Cognitive disorder—Methotrexate—esophageal cancer	0.000828	0.0149	CcSEcCtD
Simvastatin—UGT1A1—digestive system—esophageal cancer	0.000824	0.0308	CbGeAlD
Simvastatin—Infection—Carboplatin—esophageal cancer	0.000789	0.0142	CcSEcCtD
Simvastatin—Loss of libido—Methotrexate—esophageal cancer	0.000776	0.014	CcSEcCtD
Simvastatin—Tenderness—Cisplatin—esophageal cancer	0.000748	0.0135	CcSEcCtD
Simvastatin—HMGCR—digestive system—esophageal cancer	0.000715	0.0268	CbGeAlD
Simvastatin—SLCO1B1—digestive system—esophageal cancer	0.000685	0.0256	CbGeAlD
Simvastatin—Pain—Carboplatin—esophageal cancer	0.000679	0.0122	CcSEcCtD
Simvastatin—Hepatocellular injury—Cisplatin—esophageal cancer	0.000653	0.0118	CcSEcCtD
Simvastatin—Body temperature increased—Carboplatin—esophageal cancer	0.000628	0.0113	CcSEcCtD
Simvastatin—Memory impairment—Capecitabine—esophageal cancer	0.000613	0.0111	CcSEcCtD
Simvastatin—HMGCR—lung—esophageal cancer	0.000597	0.0224	CbGeAlD
Simvastatin—Lovastatin—ABCB1—esophageal cancer	0.000587	0.134	CrCbGaD
Simvastatin—Pravastatin—ABCB1—esophageal cancer	0.000587	0.134	CrCbGaD
Simvastatin—SLCO1A2—digestive system—esophageal cancer	0.000558	0.0209	CbGeAlD
Simvastatin—Proteinuria—Capecitabine—esophageal cancer	0.000548	0.00988	CcSEcCtD
Simvastatin—Protein urine present—Capecitabine—esophageal cancer	0.00054	0.00974	CcSEcCtD
Simvastatin—Liver disorder—Methotrexate—esophageal cancer	0.000525	0.00948	CcSEcCtD
Simvastatin—Haemolytic anaemia—Cisplatin—esophageal cancer	0.000525	0.00947	CcSEcCtD
Simvastatin—ABCC2—digestive system—esophageal cancer	0.000519	0.0194	CbGeAlD
Simvastatin—Interstitial lung disease—Methotrexate—esophageal cancer	0.000506	0.00913	CcSEcCtD
Simvastatin—Cataract—Capecitabine—esophageal cancer	0.000505	0.00912	CcSEcCtD
Simvastatin—Amnesia—Cisplatin—esophageal cancer	0.000504	0.0091	CcSEcCtD
Simvastatin—Inflammation—Capecitabine—esophageal cancer	0.000496	0.00895	CcSEcCtD
Simvastatin—Phosphatase alkaline increased—Capecitabine—esophageal cancer	0.000481	0.00868	CcSEcCtD
Simvastatin—SLCO1A2—lung—esophageal cancer	0.000466	0.0174	CbGeAlD
Simvastatin—CYP2B6—bronchus—esophageal cancer	0.000452	0.0169	CbGeAlD
Simvastatin—CYP2C19—digestive system—esophageal cancer	0.000446	0.0167	CbGeAlD
Simvastatin—Cramp muscle—Cisplatin—esophageal cancer	0.000427	0.00769	CcSEcCtD
Simvastatin—HMGCR—lymph node—esophageal cancer	0.000409	0.0153	CbGeAlD
Simvastatin—Proteinuria—Methotrexate—esophageal cancer	0.000408	0.00735	CcSEcCtD
Simvastatin—Sleep disorder—Capecitabine—esophageal cancer	0.000403	0.00728	CcSEcCtD
Simvastatin—Protein urine present—Methotrexate—esophageal cancer	0.000402	0.00725	CcSEcCtD
Simvastatin—Diabetes mellitus—Capecitabine—esophageal cancer	0.000402	0.00724	CcSEcCtD
Simvastatin—Blood alkaline phosphatase increased—Capecitabine—esophageal cancer	0.000402	0.00724	CcSEcCtD
Simvastatin—Pancreatitis—Cisplatin—esophageal cancer	0.000402	0.00724	CcSEcCtD
Simvastatin—Hepatic function abnormal—Capecitabine—esophageal cancer	0.0004	0.00721	CcSEcCtD
Simvastatin—Photosensitivity—Capecitabine—esophageal cancer	0.000398	0.00717	CcSEcCtD
Simvastatin—Swelling—Capecitabine—esophageal cancer	0.000396	0.00714	CcSEcCtD
Simvastatin—Abdominal discomfort—Cisplatin—esophageal cancer	0.000393	0.00708	CcSEcCtD
Simvastatin—Vascular purpura—Capecitabine—esophageal cancer	0.00039	0.00704	CcSEcCtD
Simvastatin—Hepatic failure—Capecitabine—esophageal cancer	0.000389	0.00701	CcSEcCtD
Simvastatin—Haemolytic anaemia—Capecitabine—esophageal cancer	0.000387	0.00698	CcSEcCtD
Simvastatin—Amnesia—Capecitabine—esophageal cancer	0.000372	0.0067	CcSEcCtD
Simvastatin—Inflammation—Methotrexate—esophageal cancer	0.000369	0.00666	CcSEcCtD
Simvastatin—Atrial fibrillation—Capecitabine—esophageal cancer	0.000369	0.00665	CcSEcCtD
Simvastatin—Vasculitis—Methotrexate—esophageal cancer	0.000367	0.00662	CcSEcCtD
Simvastatin—Purpura—Capecitabine—esophageal cancer	0.000362	0.00654	CcSEcCtD
Simvastatin—Arthritis—Capecitabine—esophageal cancer	0.000359	0.00648	CcSEcCtD
Simvastatin—Neuropathy peripheral—Cisplatin—esophageal cancer	0.000358	0.00646	CcSEcCtD
Simvastatin—CYP3A5—digestive system—esophageal cancer	0.000352	0.0132	CbGeAlD
Simvastatin—CYP2B6—digestive system—esophageal cancer	0.00035	0.0131	CbGeAlD
Simvastatin—CYP2C9—digestive system—esophageal cancer	0.000346	0.013	CbGeAlD
Simvastatin—Gynaecomastia—Methotrexate—esophageal cancer	0.00032	0.00578	CcSEcCtD
Simvastatin—Toxic epidermal necrolysis—Capecitabine—esophageal cancer	0.000315	0.00567	CcSEcCtD
Simvastatin—Gastritis—Capecitabine—esophageal cancer	0.000309	0.00557	CcSEcCtD
Simvastatin—Muscular weakness—Capecitabine—esophageal cancer	0.000308	0.00556	CcSEcCtD
Simvastatin—Flushing—Cisplatin—esophageal cancer	0.000304	0.00549	CcSEcCtD
Simvastatin—Diabetes mellitus—Methotrexate—esophageal cancer	0.000299	0.00539	CcSEcCtD
Simvastatin—ABCC2—lymph node—esophageal cancer	0.000297	0.0111	CbGeAlD
Simvastatin—Photosensitivity—Methotrexate—esophageal cancer	0.000296	0.00534	CcSEcCtD
Simvastatin—CYP3A5—lung—esophageal cancer	0.000294	0.011	CbGeAlD
Simvastatin—CYP2B6—lung—esophageal cancer	0.000292	0.0109	CbGeAlD
Simvastatin—Bronchitis—Capecitabine—esophageal cancer	0.00029	0.00524	CcSEcCtD
Simvastatin—Alopecia—Cisplatin—esophageal cancer	0.00029	0.00522	CcSEcCtD
Simvastatin—Abdominal discomfort—Capecitabine—esophageal cancer	0.000289	0.00522	CcSEcCtD
Simvastatin—Hepatic failure—Methotrexate—esophageal cancer	0.000289	0.00522	CcSEcCtD
Simvastatin—Erythema—Cisplatin—esophageal cancer	0.000285	0.00515	CcSEcCtD
Simvastatin—Flatulence—Cisplatin—esophageal cancer	0.000281	0.00507	CcSEcCtD
Simvastatin—Upper respiratory tract infection—Capecitabine—esophageal cancer	0.000281	0.00506	CcSEcCtD
Simvastatin—Photosensitivity reaction—Capecitabine—esophageal cancer	0.000276	0.00497	CcSEcCtD
Simvastatin—Muscle spasms—Cisplatin—esophageal cancer	0.000274	0.00495	CcSEcCtD
Simvastatin—Vision blurred—Cisplatin—esophageal cancer	0.000269	0.00485	CcSEcCtD
Simvastatin—Depression—Capecitabine—esophageal cancer	0.000268	0.00484	CcSEcCtD
Simvastatin—Tremor—Cisplatin—esophageal cancer	0.000267	0.00482	CcSEcCtD
Simvastatin—Stevens-Johnson syndrome—Capecitabine—esophageal cancer	0.000267	0.00481	CcSEcCtD
Simvastatin—Ill-defined disorder—Cisplatin—esophageal cancer	0.000265	0.00477	CcSEcCtD
Simvastatin—CYP3A4—digestive system—esophageal cancer	0.000264	0.00988	CbGeAlD
Simvastatin—Neuropathy peripheral—Capecitabine—esophageal cancer	0.000264	0.00476	CcSEcCtD
Simvastatin—Anaemia—Cisplatin—esophageal cancer	0.000264	0.00476	CcSEcCtD
Simvastatin—Jaundice—Capecitabine—esophageal cancer	0.000262	0.00473	CcSEcCtD
Simvastatin—CYP2D6—digestive system—esophageal cancer	0.00026	0.00972	CbGeAlD
Simvastatin—Malaise—Cisplatin—esophageal cancer	0.000257	0.00464	CcSEcCtD
Simvastatin—Leukopenia—Cisplatin—esophageal cancer	0.000255	0.00461	CcSEcCtD
Simvastatin—ABCB1—epithelium—esophageal cancer	0.000246	0.00919	CbGeAlD
Simvastatin—Myalgia—Cisplatin—esophageal cancer	0.000243	0.00438	CcSEcCtD
Simvastatin—Anxiety—Cisplatin—esophageal cancer	0.000242	0.00437	CcSEcCtD
Simvastatin—Hepatitis—Capecitabine—esophageal cancer	0.000242	0.00436	CcSEcCtD
Simvastatin—Discomfort—Cisplatin—esophageal cancer	0.00024	0.00433	CcSEcCtD
Simvastatin—Toxic epidermal necrolysis—Methotrexate—esophageal cancer	0.000234	0.00422	CcSEcCtD
Simvastatin—Anaphylactic shock—Cisplatin—esophageal cancer	0.000233	0.0042	CcSEcCtD
Simvastatin—Oedema—Cisplatin—esophageal cancer	0.000233	0.0042	CcSEcCtD
Simvastatin—Infection—Cisplatin—esophageal cancer	0.000231	0.00417	CcSEcCtD
Simvastatin—Erythema multiforme—Capecitabine—esophageal cancer	0.000228	0.00412	CcSEcCtD
Simvastatin—Thrombocytopenia—Cisplatin—esophageal cancer	0.000228	0.00411	CcSEcCtD
Simvastatin—Flushing—Capecitabine—esophageal cancer	0.000224	0.00404	CcSEcCtD
Simvastatin—Eosinophilia—Methotrexate—esophageal cancer	0.000222	0.00401	CcSEcCtD
Simvastatin—Anorexia—Cisplatin—esophageal cancer	0.000222	0.004	CcSEcCtD
Simvastatin—Pancreatitis—Methotrexate—esophageal cancer	0.00022	0.00397	CcSEcCtD
Simvastatin—ABCB1—trachea—esophageal cancer	0.000217	0.00813	CbGeAlD
Simvastatin—Chills—Capecitabine—esophageal cancer	0.000217	0.00391	CcSEcCtD
Simvastatin—Abdominal discomfort—Methotrexate—esophageal cancer	0.000215	0.00389	CcSEcCtD
Simvastatin—Alopecia—Capecitabine—esophageal cancer	0.000214	0.00385	CcSEcCtD
Simvastatin—Musculoskeletal discomfort—Cisplatin—esophageal cancer	0.000212	0.00383	CcSEcCtD
Simvastatin—Mental disorder—Capecitabine—esophageal cancer	0.000212	0.00382	CcSEcCtD
Simvastatin—Erythema—Capecitabine—esophageal cancer	0.00021	0.00379	CcSEcCtD
Simvastatin—Paraesthesia—Cisplatin—esophageal cancer	0.000209	0.00377	CcSEcCtD
Simvastatin—Upper respiratory tract infection—Methotrexate—esophageal cancer	0.000209	0.00377	CcSEcCtD
Simvastatin—Dyspnoea—Cisplatin—esophageal cancer	0.000208	0.00374	CcSEcCtD
Simvastatin—Flatulence—Capecitabine—esophageal cancer	0.000207	0.00374	CcSEcCtD
Simvastatin—Erectile dysfunction—Methotrexate—esophageal cancer	0.000207	0.00373	CcSEcCtD
Simvastatin—Dysgeusia—Capecitabine—esophageal cancer	0.000206	0.00371	CcSEcCtD
Simvastatin—Photosensitivity reaction—Methotrexate—esophageal cancer	0.000205	0.0037	CcSEcCtD
Simvastatin—Decreased appetite—Cisplatin—esophageal cancer	0.000202	0.00365	CcSEcCtD
Simvastatin—Muscle spasms—Capecitabine—esophageal cancer	0.000202	0.00365	CcSEcCtD
Simvastatin—Gastrointestinal disorder—Cisplatin—esophageal cancer	0.000201	0.00363	CcSEcCtD
Simvastatin—Depression—Methotrexate—esophageal cancer	0.0002	0.0036	CcSEcCtD
Simvastatin—Pain—Cisplatin—esophageal cancer	0.000199	0.00359	CcSEcCtD
Simvastatin—Stevens-Johnson syndrome—Methotrexate—esophageal cancer	0.000199	0.00358	CcSEcCtD
Simvastatin—Vision blurred—Capecitabine—esophageal cancer	0.000198	0.00358	CcSEcCtD
Simvastatin—Tremor—Capecitabine—esophageal cancer	0.000197	0.00355	CcSEcCtD
Simvastatin—Ill-defined disorder—Capecitabine—esophageal cancer	0.000195	0.00352	CcSEcCtD
Simvastatin—Anaemia—Capecitabine—esophageal cancer	0.000194	0.00351	CcSEcCtD
Simvastatin—Feeling abnormal—Cisplatin—esophageal cancer	0.000192	0.00346	CcSEcCtD
Simvastatin—Malaise—Capecitabine—esophageal cancer	0.00019	0.00342	CcSEcCtD
Simvastatin—Vertigo—Capecitabine—esophageal cancer	0.000189	0.00341	CcSEcCtD
Simvastatin—Leukopenia—Capecitabine—esophageal cancer	0.000188	0.0034	CcSEcCtD
Simvastatin—ABCB1—digestive system—esophageal cancer	0.000187	0.00699	CbGeAlD
Simvastatin—Body temperature increased—Cisplatin—esophageal cancer	0.000184	0.00332	CcSEcCtD
Simvastatin—Hepatitis—Methotrexate—esophageal cancer	0.00018	0.00324	CcSEcCtD
Simvastatin—Myalgia—Capecitabine—esophageal cancer	0.000179	0.00323	CcSEcCtD
Simvastatin—Arthralgia—Capecitabine—esophageal cancer	0.000179	0.00323	CcSEcCtD
Simvastatin—Chest pain—Capecitabine—esophageal cancer	0.000179	0.00323	CcSEcCtD
Simvastatin—Anxiety—Capecitabine—esophageal cancer	0.000178	0.00322	CcSEcCtD
Simvastatin—Discomfort—Capecitabine—esophageal cancer	0.000177	0.00319	CcSEcCtD
Simvastatin—Confusional state—Capecitabine—esophageal cancer	0.000173	0.00312	CcSEcCtD
Simvastatin—Oedema—Capecitabine—esophageal cancer	0.000172	0.0031	CcSEcCtD
Simvastatin—Hypersensitivity—Cisplatin—esophageal cancer	0.000172	0.00309	CcSEcCtD
Simvastatin—Infection—Capecitabine—esophageal cancer	0.000171	0.00308	CcSEcCtD
Simvastatin—Erythema multiforme—Methotrexate—esophageal cancer	0.00017	0.00307	CcSEcCtD
Simvastatin—Thrombocytopenia—Capecitabine—esophageal cancer	0.000168	0.00303	CcSEcCtD
Simvastatin—Asthenia—Cisplatin—esophageal cancer	0.000167	0.00301	CcSEcCtD
Simvastatin—Anorexia—Capecitabine—esophageal cancer	0.000164	0.00295	CcSEcCtD
Simvastatin—Chills—Methotrexate—esophageal cancer	0.000161	0.00291	CcSEcCtD
Simvastatin—Diarrhoea—Cisplatin—esophageal cancer	0.000159	0.00287	CcSEcCtD
Simvastatin—Alopecia—Methotrexate—esophageal cancer	0.000159	0.00287	CcSEcCtD
Simvastatin—Mental disorder—Methotrexate—esophageal cancer	0.000158	0.00284	CcSEcCtD
Simvastatin—Erythema—Methotrexate—esophageal cancer	0.000157	0.00282	CcSEcCtD
Simvastatin—Musculoskeletal discomfort—Capecitabine—esophageal cancer	0.000156	0.00282	CcSEcCtD
Simvastatin—ABCB1—lung—esophageal cancer	0.000156	0.00584	CbGeAlD
Simvastatin—Insomnia—Capecitabine—esophageal cancer	0.000155	0.0028	CcSEcCtD
Simvastatin—Paraesthesia—Capecitabine—esophageal cancer	0.000154	0.00278	CcSEcCtD
Simvastatin—Dysgeusia—Methotrexate—esophageal cancer	0.000153	0.00277	CcSEcCtD
Simvastatin—Dyspnoea—Capecitabine—esophageal cancer	0.000153	0.00276	CcSEcCtD
Simvastatin—Dyspepsia—Capecitabine—esophageal cancer	0.000151	0.00273	CcSEcCtD
Simvastatin—Decreased appetite—Capecitabine—esophageal cancer	0.000149	0.00269	CcSEcCtD
Simvastatin—Gastrointestinal disorder—Capecitabine—esophageal cancer	0.000148	0.00267	CcSEcCtD
Simvastatin—Vomiting—Cisplatin—esophageal cancer	0.000148	0.00267	CcSEcCtD
Simvastatin—Fatigue—Capecitabine—esophageal cancer	0.000148	0.00267	CcSEcCtD
Simvastatin—Vision blurred—Methotrexate—esophageal cancer	0.000148	0.00266	CcSEcCtD
Simvastatin—Rash—Cisplatin—esophageal cancer	0.000147	0.00265	CcSEcCtD
Simvastatin—Pain—Capecitabine—esophageal cancer	0.000147	0.00265	CcSEcCtD
Simvastatin—Constipation—Capecitabine—esophageal cancer	0.000147	0.00265	CcSEcCtD
Simvastatin—Dermatitis—Cisplatin—esophageal cancer	0.000147	0.00265	CcSEcCtD
Simvastatin—Ill-defined disorder—Methotrexate—esophageal cancer	0.000145	0.00262	CcSEcCtD
Simvastatin—Anaemia—Methotrexate—esophageal cancer	0.000145	0.00261	CcSEcCtD
Simvastatin—Feeling abnormal—Capecitabine—esophageal cancer	0.000141	0.00255	CcSEcCtD
Simvastatin—Malaise—Methotrexate—esophageal cancer	0.000141	0.00255	CcSEcCtD
Simvastatin—Vertigo—Methotrexate—esophageal cancer	0.000141	0.00254	CcSEcCtD
Simvastatin—Gastrointestinal pain—Capecitabine—esophageal cancer	0.00014	0.00253	CcSEcCtD
Simvastatin—Leukopenia—Methotrexate—esophageal cancer	0.00014	0.00253	CcSEcCtD
Simvastatin—Nausea—Cisplatin—esophageal cancer	0.000138	0.00249	CcSEcCtD
Simvastatin—Urticaria—Capecitabine—esophageal cancer	0.000136	0.00246	CcSEcCtD
Simvastatin—Abdominal pain—Capecitabine—esophageal cancer	0.000136	0.00245	CcSEcCtD
Simvastatin—Body temperature increased—Capecitabine—esophageal cancer	0.000136	0.00245	CcSEcCtD
Simvastatin—Arthralgia—Methotrexate—esophageal cancer	0.000133	0.0024	CcSEcCtD
Simvastatin—Chest pain—Methotrexate—esophageal cancer	0.000133	0.0024	CcSEcCtD
Simvastatin—Myalgia—Methotrexate—esophageal cancer	0.000133	0.0024	CcSEcCtD
Simvastatin—Discomfort—Methotrexate—esophageal cancer	0.000132	0.00238	CcSEcCtD
Simvastatin—Confusional state—Methotrexate—esophageal cancer	0.000129	0.00232	CcSEcCtD
Simvastatin—Anaphylactic shock—Methotrexate—esophageal cancer	0.000128	0.0023	CcSEcCtD
Simvastatin—Infection—Methotrexate—esophageal cancer	0.000127	0.00229	CcSEcCtD
Simvastatin—Hypersensitivity—Capecitabine—esophageal cancer	0.000126	0.00228	CcSEcCtD
Simvastatin—Thrombocytopenia—Methotrexate—esophageal cancer	0.000125	0.00226	CcSEcCtD
Simvastatin—Asthenia—Capecitabine—esophageal cancer	0.000123	0.00222	CcSEcCtD
Simvastatin—Anorexia—Methotrexate—esophageal cancer	0.000122	0.0022	CcSEcCtD
Simvastatin—Pruritus—Capecitabine—esophageal cancer	0.000121	0.00219	CcSEcCtD
Simvastatin—Diarrhoea—Capecitabine—esophageal cancer	0.000117	0.00212	CcSEcCtD
Simvastatin—Musculoskeletal discomfort—Methotrexate—esophageal cancer	0.000116	0.0021	CcSEcCtD
Simvastatin—Insomnia—Methotrexate—esophageal cancer	0.000116	0.00208	CcSEcCtD
Simvastatin—Paraesthesia—Methotrexate—esophageal cancer	0.000115	0.00207	CcSEcCtD
Simvastatin—Dyspnoea—Methotrexate—esophageal cancer	0.000114	0.00205	CcSEcCtD
Simvastatin—Dizziness—Capecitabine—esophageal cancer	0.000114	0.00205	CcSEcCtD
Simvastatin—Dyspepsia—Methotrexate—esophageal cancer	0.000112	0.00203	CcSEcCtD
Simvastatin—Decreased appetite—Methotrexate—esophageal cancer	0.000111	0.002	CcSEcCtD
Simvastatin—Gastrointestinal disorder—Methotrexate—esophageal cancer	0.00011	0.00199	CcSEcCtD
Simvastatin—Fatigue—Methotrexate—esophageal cancer	0.00011	0.00199	CcSEcCtD
Simvastatin—Pain—Methotrexate—esophageal cancer	0.000109	0.00197	CcSEcCtD
Simvastatin—Vomiting—Capecitabine—esophageal cancer	0.000109	0.00197	CcSEcCtD
Simvastatin—Rash—Capecitabine—esophageal cancer	0.000108	0.00195	CcSEcCtD
Simvastatin—Dermatitis—Capecitabine—esophageal cancer	0.000108	0.00195	CcSEcCtD
Simvastatin—Headache—Capecitabine—esophageal cancer	0.000108	0.00194	CcSEcCtD
Simvastatin—ABCB1—lymph node—esophageal cancer	0.000107	0.00399	CbGeAlD
Simvastatin—Feeling abnormal—Methotrexate—esophageal cancer	0.000105	0.0019	CcSEcCtD
Simvastatin—Gastrointestinal pain—Methotrexate—esophageal cancer	0.000104	0.00188	CcSEcCtD
Simvastatin—Nausea—Capecitabine—esophageal cancer	0.000102	0.00184	CcSEcCtD
Simvastatin—Urticaria—Methotrexate—esophageal cancer	0.000102	0.00183	CcSEcCtD
Simvastatin—Body temperature increased—Methotrexate—esophageal cancer	0.000101	0.00182	CcSEcCtD
Simvastatin—Abdominal pain—Methotrexate—esophageal cancer	0.000101	0.00182	CcSEcCtD
Simvastatin—Hypersensitivity—Methotrexate—esophageal cancer	9.42e-05	0.0017	CcSEcCtD
Simvastatin—Asthenia—Methotrexate—esophageal cancer	9.17e-05	0.00165	CcSEcCtD
Simvastatin—Pruritus—Methotrexate—esophageal cancer	9.04e-05	0.00163	CcSEcCtD
Simvastatin—Diarrhoea—Methotrexate—esophageal cancer	8.74e-05	0.00158	CcSEcCtD
Simvastatin—Dizziness—Methotrexate—esophageal cancer	8.45e-05	0.00152	CcSEcCtD
Simvastatin—Vomiting—Methotrexate—esophageal cancer	8.13e-05	0.00147	CcSEcCtD
Simvastatin—Rash—Methotrexate—esophageal cancer	8.06e-05	0.00145	CcSEcCtD
Simvastatin—Dermatitis—Methotrexate—esophageal cancer	8.05e-05	0.00145	CcSEcCtD
Simvastatin—Headache—Methotrexate—esophageal cancer	8.01e-05	0.00144	CcSEcCtD
Simvastatin—Nausea—Methotrexate—esophageal cancer	7.59e-05	0.00137	CcSEcCtD
Simvastatin—CYP3A5—Metabolism—GNG7—esophageal cancer	1.13e-05	8.6e-05	CbGpPWpGaD
Simvastatin—CYP2C8—Metabolism—TPI1—esophageal cancer	1.13e-05	8.56e-05	CbGpPWpGaD
Simvastatin—CYP2C8—Metabolism—GSTO1—esophageal cancer	1.13e-05	8.56e-05	CbGpPWpGaD
Simvastatin—CYP2C19—Metabolism—TYMP—esophageal cancer	1.11e-05	8.45e-05	CbGpPWpGaD
Simvastatin—CYP3A7—Metabolism—CYP1B1—esophageal cancer	1.11e-05	8.44e-05	CbGpPWpGaD
Simvastatin—ABCB1—Transmembrane transport of small molecules—HMOX1—esophageal cancer	1.11e-05	8.44e-05	CbGpPWpGaD
Simvastatin—CYP3A4—Metabolism—BLVRB—esophageal cancer	1.1e-05	8.38e-05	CbGpPWpGaD
Simvastatin—CYP3A4—Metabolism—SLC52A3—esophageal cancer	1.1e-05	8.38e-05	CbGpPWpGaD
Simvastatin—UGT1A1—Metabolism—ABCB1—esophageal cancer	1.09e-05	8.27e-05	CbGpPWpGaD
Simvastatin—ABCB1—Metabolism—TYMP—esophageal cancer	1.08e-05	8.24e-05	CbGpPWpGaD
Simvastatin—CYP2B6—Metabolism—ALDH2—esophageal cancer	1.08e-05	8.24e-05	CbGpPWpGaD
Simvastatin—CYP2C19—Metabolism—CYP26A1—esophageal cancer	1.08e-05	8.22e-05	CbGpPWpGaD
Simvastatin—CYP2C8—Metabolism—ALDOB—esophageal cancer	1.08e-05	8.2e-05	CbGpPWpGaD
Simvastatin—CYP2D6—Metabolism—ADH1B—esophageal cancer	1.07e-05	8.13e-05	CbGpPWpGaD
Simvastatin—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—esophageal cancer	1.06e-05	8.09e-05	CbGpPWpGaD
Simvastatin—CYP2C9—Metabolism—ADH1B—esophageal cancer	1.06e-05	8.06e-05	CbGpPWpGaD
Simvastatin—CYP3A5—Metabolism—ALDH2—esophageal cancer	1.06e-05	8.05e-05	CbGpPWpGaD
Simvastatin—HMGCR—Metabolism—PTGS2—esophageal cancer	1.06e-05	8.03e-05	CbGpPWpGaD
Simvastatin—ABCB1—Metabolism—CYP26A1—esophageal cancer	1.05e-05	8.02e-05	CbGpPWpGaD
Simvastatin—CYP2C19—Metabolism—ALOX15—esophageal cancer	1.05e-05	8.01e-05	CbGpPWpGaD
Simvastatin—UGT1A3—Metabolism—CREBBP—esophageal cancer	1.05e-05	8e-05	CbGpPWpGaD
Simvastatin—CYP3A7—Metabolism—CYP19A1—esophageal cancer	1.04e-05	7.94e-05	CbGpPWpGaD
Simvastatin—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—esophageal cancer	1.04e-05	7.91e-05	CbGpPWpGaD
Simvastatin—CYP2C8—Metabolism—GAPDH—esophageal cancer	1.04e-05	7.9e-05	CbGpPWpGaD
Simvastatin—SLCO1B1—Metabolism—HMOX1—esophageal cancer	1.04e-05	7.89e-05	CbGpPWpGaD
Simvastatin—CYP2B6—Metabolism—GSTT1—esophageal cancer	1.03e-05	7.84e-05	CbGpPWpGaD
Simvastatin—CYP2C8—Metabolism—CRABP1—esophageal cancer	1.03e-05	7.83e-05	CbGpPWpGaD
Simvastatin—ABCB1—Metabolism—ALOX15—esophageal cancer	1.03e-05	7.81e-05	CbGpPWpGaD
Simvastatin—CYP2D6—Metabolism—TYMP—esophageal cancer	1.02e-05	7.77e-05	CbGpPWpGaD
Simvastatin—CYP2B6—Metabolism—CYP2A6—esophageal cancer	1.02e-05	7.75e-05	CbGpPWpGaD
Simvastatin—SLCO1B1—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	1.02e-05	7.74e-05	CbGpPWpGaD
Simvastatin—CYP2C9—Metabolism—TYMP—esophageal cancer	1.01e-05	7.7e-05	CbGpPWpGaD
Simvastatin—CYP3A5—Metabolism—GSTT1—esophageal cancer	1.01e-05	7.66e-05	CbGpPWpGaD
Simvastatin—CYP2C19—Metabolism—GSTO1—esophageal cancer	1e-05	7.64e-05	CbGpPWpGaD
Simvastatin—CYP2C19—Metabolism—TPI1—esophageal cancer	1e-05	7.64e-05	CbGpPWpGaD
Simvastatin—SLCO1B1—Metabolism—ABCB1—esophageal cancer	9.97e-06	7.58e-05	CbGpPWpGaD
Simvastatin—CYP3A5—Metabolism—CYP2A6—esophageal cancer	9.96e-06	7.57e-05	CbGpPWpGaD
Simvastatin—CYP2D6—Metabolism—CYP26A1—esophageal cancer	9.94e-06	7.56e-05	CbGpPWpGaD
Simvastatin—CYP2C9—Metabolism—CYP26A1—esophageal cancer	9.86e-06	7.49e-05	CbGpPWpGaD
Simvastatin—ABCB1—Metabolism—TPI1—esophageal cancer	9.81e-06	7.46e-05	CbGpPWpGaD
Simvastatin—ABCB1—Metabolism—GSTO1—esophageal cancer	9.81e-06	7.46e-05	CbGpPWpGaD
Simvastatin—CYP2C8—Metabolism—GNG7—esophageal cancer	9.79e-06	7.44e-05	CbGpPWpGaD
Simvastatin—CYP2D6—Metabolism—ALOX15—esophageal cancer	9.69e-06	7.36e-05	CbGpPWpGaD
Simvastatin—CYP2B6—Metabolism—ENO1—esophageal cancer	9.66e-06	7.34e-05	CbGpPWpGaD
Simvastatin—CYP2B6—Metabolism—PTGS1—esophageal cancer	9.66e-06	7.34e-05	CbGpPWpGaD
Simvastatin—CYP2C19—Metabolism—ALDOB—esophageal cancer	9.63e-06	7.32e-05	CbGpPWpGaD
Simvastatin—CYP2C9—Metabolism—ALOX15—esophageal cancer	9.6e-06	7.3e-05	CbGpPWpGaD
Simvastatin—CYP3A7—Metabolism—HMOX1—esophageal cancer	9.53e-06	7.24e-05	CbGpPWpGaD
Simvastatin—CYP2B6—Metabolism—PSME2—esophageal cancer	9.52e-06	7.24e-05	CbGpPWpGaD
Simvastatin—CYP2B6—Metabolism—PSME1—esophageal cancer	9.52e-06	7.24e-05	CbGpPWpGaD
Simvastatin—CYP3A5—Metabolism—ENO1—esophageal cancer	9.44e-06	7.18e-05	CbGpPWpGaD
Simvastatin—CYP3A5—Metabolism—PTGS1—esophageal cancer	9.44e-06	7.18e-05	CbGpPWpGaD
Simvastatin—UGT1A3—Metabolism—NOS3—esophageal cancer	9.42e-06	7.16e-05	CbGpPWpGaD
Simvastatin—ABCB1—Metabolism—ALDOB—esophageal cancer	9.4e-06	7.15e-05	CbGpPWpGaD
Simvastatin—CYP3A4—Metabolism—CA1—esophageal cancer	9.38e-06	7.13e-05	CbGpPWpGaD
Simvastatin—CYP3A4—Metabolism—SLC10A2—esophageal cancer	9.38e-06	7.13e-05	CbGpPWpGaD
Simvastatin—CYP3A5—Metabolism—PSME1—esophageal cancer	9.31e-06	7.07e-05	CbGpPWpGaD
Simvastatin—CYP3A5—Metabolism—PSME2—esophageal cancer	9.31e-06	7.07e-05	CbGpPWpGaD
Simvastatin—CYP2C19—Metabolism—GAPDH—esophageal cancer	9.27e-06	7.05e-05	CbGpPWpGaD
Simvastatin—CYP2D6—Metabolism—TPI1—esophageal cancer	9.24e-06	7.03e-05	CbGpPWpGaD
Simvastatin—CYP2D6—Metabolism—GSTO1—esophageal cancer	9.24e-06	7.03e-05	CbGpPWpGaD
Simvastatin—CYP2C19—Metabolism—CRABP1—esophageal cancer	9.19e-06	6.99e-05	CbGpPWpGaD
Simvastatin—CYP2C8—Metabolism—ALDH2—esophageal cancer	9.18e-06	6.98e-05	CbGpPWpGaD
Simvastatin—CYP2C9—Metabolism—TPI1—esophageal cancer	9.16e-06	6.96e-05	CbGpPWpGaD
Simvastatin—CYP2C9—Metabolism—GSTO1—esophageal cancer	9.16e-06	6.96e-05	CbGpPWpGaD
Simvastatin—CYP3A7—Metabolism—ABCB1—esophageal cancer	9.15e-06	6.95e-05	CbGpPWpGaD
Simvastatin—ABCB1—Metabolism—GAPDH—esophageal cancer	9.05e-06	6.88e-05	CbGpPWpGaD
Simvastatin—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—esophageal cancer	9.03e-06	6.87e-05	CbGpPWpGaD
Simvastatin—ABCB1—Metabolism—CRABP1—esophageal cancer	8.97e-06	6.82e-05	CbGpPWpGaD
Simvastatin—UGT2B7—Metabolism—CREBBP—esophageal cancer	8.95e-06	6.8e-05	CbGpPWpGaD
Simvastatin—CYP2D6—Metabolism—ALDOB—esophageal cancer	8.86e-06	6.74e-05	CbGpPWpGaD
Simvastatin—SLCO1A2—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	8.81e-06	6.7e-05	CbGpPWpGaD
Simvastatin—HMGCR—Metabolism—EP300—esophageal cancer	8.79e-06	6.68e-05	CbGpPWpGaD
Simvastatin—CYP2C9—Metabolism—ALDOB—esophageal cancer	8.78e-06	6.68e-05	CbGpPWpGaD
Simvastatin—CYP2C19—Metabolism—GNG7—esophageal cancer	8.74e-06	6.64e-05	CbGpPWpGaD
Simvastatin—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—esophageal cancer	8.74e-06	6.64e-05	CbGpPWpGaD
Simvastatin—CYP2C8—Metabolism—GSTT1—esophageal cancer	8.73e-06	6.64e-05	CbGpPWpGaD
Simvastatin—CYP2C8—Metabolism—CYP2A6—esophageal cancer	8.63e-06	6.56e-05	CbGpPWpGaD
Simvastatin—UGT1A3—Metabolism—PTGS2—esophageal cancer	8.62e-06	6.55e-05	CbGpPWpGaD
Simvastatin—CYP2C8—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	8.6e-06	6.53e-05	CbGpPWpGaD
Simvastatin—CYP3A4—Metabolism—CA2—esophageal cancer	8.58e-06	6.52e-05	CbGpPWpGaD
Simvastatin—ABCB1—Metabolism—GNG7—esophageal cancer	8.53e-06	6.49e-05	CbGpPWpGaD
Simvastatin—CYP2D6—Metabolism—GAPDH—esophageal cancer	8.53e-06	6.48e-05	CbGpPWpGaD
Simvastatin—CYP2C9—Metabolism—GAPDH—esophageal cancer	8.46e-06	6.43e-05	CbGpPWpGaD
Simvastatin—CYP2D6—Metabolism—CRABP1—esophageal cancer	8.45e-06	6.43e-05	CbGpPWpGaD
Simvastatin—CYP2C9—Metabolism—CRABP1—esophageal cancer	8.38e-06	6.37e-05	CbGpPWpGaD
Simvastatin—CYP2B6—Metabolism—CYP1B1—esophageal cancer	8.22e-06	6.24e-05	CbGpPWpGaD
Simvastatin—CYP2C19—Metabolism—ALDH2—esophageal cancer	8.19e-06	6.23e-05	CbGpPWpGaD
Simvastatin—CYP2C8—Metabolism—PTGS1—esophageal cancer	8.18e-06	6.22e-05	CbGpPWpGaD
Simvastatin—CYP2C8—Metabolism—ENO1—esophageal cancer	8.18e-06	6.22e-05	CbGpPWpGaD
Simvastatin—CYP2C8—Metabolism—PSME1—esophageal cancer	8.06e-06	6.13e-05	CbGpPWpGaD
Simvastatin—CYP2C8—Metabolism—PSME2—esophageal cancer	8.06e-06	6.13e-05	CbGpPWpGaD
Simvastatin—CYP2D6—Metabolism—GNG7—esophageal cancer	8.04e-06	6.11e-05	CbGpPWpGaD
Simvastatin—CYP3A5—Metabolism—CYP1B1—esophageal cancer	8.03e-06	6.1e-05	CbGpPWpGaD
Simvastatin—UGT2B7—Metabolism—NOS3—esophageal cancer	8.01e-06	6.09e-05	CbGpPWpGaD
Simvastatin—ABCB1—Metabolism—ALDH2—esophageal cancer	8e-06	6.08e-05	CbGpPWpGaD
Simvastatin—CYP3A4—Metabolism—PLCE1—esophageal cancer	7.97e-06	6.06e-05	CbGpPWpGaD
Simvastatin—CYP3A4—Metabolism—ADH7—esophageal cancer	7.97e-06	6.06e-05	CbGpPWpGaD
Simvastatin—CYP2C9—Metabolism—GNG7—esophageal cancer	7.97e-06	6.06e-05	CbGpPWpGaD
Simvastatin—CYP2C19—Metabolism—GSTT1—esophageal cancer	7.79e-06	5.92e-05	CbGpPWpGaD
Simvastatin—SLCO1A2—Metabolism—CREBBP—esophageal cancer	7.79e-06	5.92e-05	CbGpPWpGaD
Simvastatin—CYP2B6—Metabolism—CYP19A1—esophageal cancer	7.72e-06	5.87e-05	CbGpPWpGaD
Simvastatin—CYP2C19—Metabolism—CYP2A6—esophageal cancer	7.7e-06	5.85e-05	CbGpPWpGaD
Simvastatin—CYP2C19—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	7.67e-06	5.83e-05	CbGpPWpGaD
Simvastatin—ABCB1—Metabolism—GSTT1—esophageal cancer	7.6e-06	5.78e-05	CbGpPWpGaD
Simvastatin—CYP3A5—Metabolism—CYP19A1—esophageal cancer	7.55e-06	5.74e-05	CbGpPWpGaD
Simvastatin—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	7.54e-06	5.73e-05	CbGpPWpGaD
Simvastatin—CYP2D6—Metabolism—ALDH2—esophageal cancer	7.53e-06	5.73e-05	CbGpPWpGaD
Simvastatin—ABCB1—Metabolism—CYP2A6—esophageal cancer	7.52e-06	5.71e-05	CbGpPWpGaD
Simvastatin—CYP2C9—Metabolism—ALDH2—esophageal cancer	7.47e-06	5.68e-05	CbGpPWpGaD
Simvastatin—UGT2B7—Metabolism—PTGS2—esophageal cancer	7.33e-06	5.57e-05	CbGpPWpGaD
Simvastatin—CYP2C19—Metabolism—ENO1—esophageal cancer	7.3e-06	5.55e-05	CbGpPWpGaD
Simvastatin—CYP2C19—Metabolism—PTGS1—esophageal cancer	7.3e-06	5.55e-05	CbGpPWpGaD
Simvastatin—UGT1A1—Metabolism—CREBBP—esophageal cancer	7.27e-06	5.53e-05	CbGpPWpGaD
Simvastatin—CYP2C19—Metabolism—PSME2—esophageal cancer	7.19e-06	5.47e-05	CbGpPWpGaD
Simvastatin—CYP2C19—Metabolism—PSME1—esophageal cancer	7.19e-06	5.47e-05	CbGpPWpGaD
Simvastatin—CYP2D6—Metabolism—GSTT1—esophageal cancer	7.17e-06	5.45e-05	CbGpPWpGaD
Simvastatin—UGT1A3—Metabolism—EP300—esophageal cancer	7.17e-06	5.45e-05	CbGpPWpGaD
Simvastatin—ABCB1—Metabolism—PTGS1—esophageal cancer	7.13e-06	5.42e-05	CbGpPWpGaD
Simvastatin—ABCB1—Metabolism—ENO1—esophageal cancer	7.13e-06	5.42e-05	CbGpPWpGaD
Simvastatin—ABCB1—Transmembrane transport of small molecules—CREBBP—esophageal cancer	7.12e-06	5.41e-05	CbGpPWpGaD
Simvastatin—CYP2C9—Metabolism—GSTT1—esophageal cancer	7.1e-06	5.4e-05	CbGpPWpGaD
Simvastatin—CYP2D6—Metabolism—CYP2A6—esophageal cancer	7.08e-06	5.38e-05	CbGpPWpGaD
Simvastatin—CYP2B6—Metabolism—HMOX1—esophageal cancer	7.05e-06	5.36e-05	CbGpPWpGaD
Simvastatin—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	7.04e-06	5.35e-05	CbGpPWpGaD
Simvastatin—CYP2C9—Metabolism—CYP2A6—esophageal cancer	7.02e-06	5.34e-05	CbGpPWpGaD
Simvastatin—ABCB1—Metabolism—PSME2—esophageal cancer	7.02e-06	5.34e-05	CbGpPWpGaD
Simvastatin—ABCB1—Metabolism—PSME1—esophageal cancer	7.02e-06	5.34e-05	CbGpPWpGaD
Simvastatin—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	7e-06	5.32e-05	CbGpPWpGaD
Simvastatin—CYP3A4—Metabolism—ADH1B—esophageal cancer	6.99e-06	5.31e-05	CbGpPWpGaD
Simvastatin—SLCO1A2—Metabolism—NOS3—esophageal cancer	6.97e-06	5.3e-05	CbGpPWpGaD
Simvastatin—CYP2C8—Metabolism—CYP1B1—esophageal cancer	6.96e-06	5.29e-05	CbGpPWpGaD
Simvastatin—CYP3A5—Metabolism—HMOX1—esophageal cancer	6.89e-06	5.24e-05	CbGpPWpGaD
Simvastatin—CYP2B6—Metabolism—ABCB1—esophageal cancer	6.77e-06	5.14e-05	CbGpPWpGaD
Simvastatin—CYP2D6—Metabolism—ENO1—esophageal cancer	6.72e-06	5.1e-05	CbGpPWpGaD
Simvastatin—CYP2D6—Metabolism—PTGS1—esophageal cancer	6.72e-06	5.1e-05	CbGpPWpGaD
Simvastatin—CYP3A4—Metabolism—TYMP—esophageal cancer	6.68e-06	5.08e-05	CbGpPWpGaD
Simvastatin—SLCO1B1—Metabolism—CREBBP—esophageal cancer	6.66e-06	5.06e-05	CbGpPWpGaD
Simvastatin—CYP2C9—Metabolism—PTGS1—esophageal cancer	6.66e-06	5.06e-05	CbGpPWpGaD
Simvastatin—CYP2C9—Metabolism—ENO1—esophageal cancer	6.66e-06	5.06e-05	CbGpPWpGaD
Simvastatin—CYP2D6—Metabolism—PSME1—esophageal cancer	6.62e-06	5.03e-05	CbGpPWpGaD
Simvastatin—CYP2D6—Metabolism—PSME2—esophageal cancer	6.62e-06	5.03e-05	CbGpPWpGaD
Simvastatin—CYP3A5—Metabolism—ABCB1—esophageal cancer	6.61e-06	5.03e-05	CbGpPWpGaD
Simvastatin—CYP2C9—Metabolism—PSME2—esophageal cancer	6.56e-06	4.99e-05	CbGpPWpGaD
Simvastatin—CYP2C9—Metabolism—PSME1—esophageal cancer	6.56e-06	4.99e-05	CbGpPWpGaD
Simvastatin—CYP2C8—Metabolism—CYP19A1—esophageal cancer	6.54e-06	4.97e-05	CbGpPWpGaD
Simvastatin—UGT1A1—Metabolism—NOS3—esophageal cancer	6.51e-06	4.95e-05	CbGpPWpGaD
Simvastatin—HMGCR—Metabolism—PIK3CA—esophageal cancer	6.5e-06	4.94e-05	CbGpPWpGaD
Simvastatin—CYP3A4—Metabolism—CYP26A1—esophageal cancer	6.5e-06	4.94e-05	CbGpPWpGaD
Simvastatin—SLCO1A2—Metabolism—PTGS2—esophageal cancer	6.38e-06	4.85e-05	CbGpPWpGaD
Simvastatin—CYP3A4—Metabolism—ALOX15—esophageal cancer	6.33e-06	4.81e-05	CbGpPWpGaD
Simvastatin—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	6.28e-06	4.78e-05	CbGpPWpGaD
Simvastatin—CYP2C19—Metabolism—CYP1B1—esophageal cancer	6.21e-06	4.72e-05	CbGpPWpGaD
Simvastatin—CYP3A7—Metabolism—CREBBP—esophageal cancer	6.11e-06	4.65e-05	CbGpPWpGaD
Simvastatin—UGT2B7—Metabolism—EP300—esophageal cancer	6.09e-06	4.63e-05	CbGpPWpGaD
Simvastatin—ABCB1—Metabolism—CYP1B1—esophageal cancer	6.06e-06	4.61e-05	CbGpPWpGaD
Simvastatin—CYP3A4—Metabolism—TPI1—esophageal cancer	6.04e-06	4.59e-05	CbGpPWpGaD
Simvastatin—CYP3A4—Metabolism—GSTO1—esophageal cancer	6.04e-06	4.59e-05	CbGpPWpGaD
Simvastatin—CYP2C8—Metabolism—HMOX1—esophageal cancer	5.97e-06	4.54e-05	CbGpPWpGaD
Simvastatin—SLCO1B1—Metabolism—NOS3—esophageal cancer	5.96e-06	4.53e-05	CbGpPWpGaD
Simvastatin—UGT1A1—Metabolism—PTGS2—esophageal cancer	5.95e-06	4.53e-05	CbGpPWpGaD
Simvastatin—CYP2C8—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	5.85e-06	4.45e-05	CbGpPWpGaD
Simvastatin—CYP2C19—Metabolism—CYP19A1—esophageal cancer	5.84e-06	4.44e-05	CbGpPWpGaD
Simvastatin—CYP3A4—Metabolism—ALDOB—esophageal cancer	5.79e-06	4.4e-05	CbGpPWpGaD
Simvastatin—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	5.73e-06	4.35e-05	CbGpPWpGaD
Simvastatin—CYP2C8—Metabolism—ABCB1—esophageal cancer	5.73e-06	4.35e-05	CbGpPWpGaD
Simvastatin—CYP2D6—Metabolism—CYP1B1—esophageal cancer	5.71e-06	4.34e-05	CbGpPWpGaD
Simvastatin—ABCB1—Metabolism—CYP19A1—esophageal cancer	5.7e-06	4.33e-05	CbGpPWpGaD
Simvastatin—CYP2C9—Metabolism—CYP1B1—esophageal cancer	5.66e-06	4.3e-05	CbGpPWpGaD
Simvastatin—CYP3A4—Metabolism—GAPDH—esophageal cancer	5.58e-06	4.24e-05	CbGpPWpGaD
Simvastatin—CYP3A4—Metabolism—CRABP1—esophageal cancer	5.53e-06	4.2e-05	CbGpPWpGaD
Simvastatin—CYP3A7—Metabolism—NOS3—esophageal cancer	5.47e-06	4.16e-05	CbGpPWpGaD
Simvastatin—SLCO1B1—Metabolism—PTGS2—esophageal cancer	5.46e-06	4.15e-05	CbGpPWpGaD
Simvastatin—CYP2D6—Metabolism—CYP19A1—esophageal cancer	5.37e-06	4.08e-05	CbGpPWpGaD
Simvastatin—CYP2C19—Metabolism—HMOX1—esophageal cancer	5.33e-06	4.05e-05	CbGpPWpGaD
Simvastatin—CYP2C9—Metabolism—CYP19A1—esophageal cancer	5.32e-06	4.05e-05	CbGpPWpGaD
Simvastatin—SLCO1A2—Metabolism—EP300—esophageal cancer	5.31e-06	4.03e-05	CbGpPWpGaD
Simvastatin—UGT1A3—Metabolism—PIK3CA—esophageal cancer	5.3e-06	4.03e-05	CbGpPWpGaD
Simvastatin—CYP3A4—Metabolism—GNG7—esophageal cancer	5.26e-06	4e-05	CbGpPWpGaD
Simvastatin—CYP2C19—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	5.23e-06	3.97e-05	CbGpPWpGaD
Simvastatin—ABCB1—Metabolism—HMOX1—esophageal cancer	5.2e-06	3.95e-05	CbGpPWpGaD
Simvastatin—CYP2C19—Metabolism—ABCB1—esophageal cancer	5.11e-06	3.89e-05	CbGpPWpGaD
Simvastatin—CYP3A7—Metabolism—PTGS2—esophageal cancer	5.01e-06	3.81e-05	CbGpPWpGaD
Simvastatin—UGT1A1—Metabolism—EP300—esophageal cancer	4.95e-06	3.76e-05	CbGpPWpGaD
Simvastatin—CYP3A4—Metabolism—ALDH2—esophageal cancer	4.93e-06	3.74e-05	CbGpPWpGaD
Simvastatin—CYP2D6—Metabolism—HMOX1—esophageal cancer	4.9e-06	3.72e-05	CbGpPWpGaD
Simvastatin—CYP2C9—Metabolism—HMOX1—esophageal cancer	4.86e-06	3.69e-05	CbGpPWpGaD
Simvastatin—CYP2C9—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	4.76e-06	3.62e-05	CbGpPWpGaD
Simvastatin—CYP2D6—Metabolism—ABCB1—esophageal cancer	4.7e-06	3.57e-05	CbGpPWpGaD
Simvastatin—CYP3A4—Metabolism—GSTT1—esophageal cancer	4.69e-06	3.56e-05	CbGpPWpGaD
Simvastatin—CYP2C9—Metabolism—ABCB1—esophageal cancer	4.66e-06	3.54e-05	CbGpPWpGaD
Simvastatin—CYP3A4—Metabolism—CYP2A6—esophageal cancer	4.63e-06	3.52e-05	CbGpPWpGaD
Simvastatin—SLCO1B1—Metabolism—EP300—esophageal cancer	4.54e-06	3.45e-05	CbGpPWpGaD
Simvastatin—CYP2B6—Metabolism—CREBBP—esophageal cancer	4.52e-06	3.44e-05	CbGpPWpGaD
Simvastatin—UGT2B7—Metabolism—PIK3CA—esophageal cancer	4.51e-06	3.43e-05	CbGpPWpGaD
Simvastatin—CYP3A5—Metabolism—CREBBP—esophageal cancer	4.42e-06	3.36e-05	CbGpPWpGaD
Simvastatin—CYP3A4—Metabolism—ENO1—esophageal cancer	4.39e-06	3.34e-05	CbGpPWpGaD
Simvastatin—CYP3A4—Metabolism—PTGS1—esophageal cancer	4.39e-06	3.34e-05	CbGpPWpGaD
Simvastatin—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	4.33e-06	3.29e-05	CbGpPWpGaD
Simvastatin—CYP3A4—Metabolism—PSME2—esophageal cancer	4.33e-06	3.29e-05	CbGpPWpGaD
Simvastatin—CYP3A4—Metabolism—PSME1—esophageal cancer	4.33e-06	3.29e-05	CbGpPWpGaD
Simvastatin—CYP3A7—Metabolism—EP300—esophageal cancer	4.16e-06	3.17e-05	CbGpPWpGaD
Simvastatin—CYP2B6—Metabolism—NOS3—esophageal cancer	4.05e-06	3.08e-05	CbGpPWpGaD
Simvastatin—CYP3A5—Metabolism—NOS3—esophageal cancer	3.96e-06	3.01e-05	CbGpPWpGaD
Simvastatin—SLCO1A2—Metabolism—PIK3CA—esophageal cancer	3.92e-06	2.98e-05	CbGpPWpGaD
Simvastatin—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	3.87e-06	2.94e-05	CbGpPWpGaD
Simvastatin—CYP2C8—Metabolism—CREBBP—esophageal cancer	3.83e-06	2.91e-05	CbGpPWpGaD
Simvastatin—CYP3A4—Metabolism—CYP1B1—esophageal cancer	3.73e-06	2.84e-05	CbGpPWpGaD
Simvastatin—CYP2B6—Metabolism—PTGS2—esophageal cancer	3.7e-06	2.81e-05	CbGpPWpGaD
Simvastatin—UGT1A1—Metabolism—PIK3CA—esophageal cancer	3.66e-06	2.78e-05	CbGpPWpGaD
Simvastatin—CYP3A5—Metabolism—PTGS2—esophageal cancer	3.62e-06	2.75e-05	CbGpPWpGaD
Simvastatin—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	3.52e-06	2.68e-05	CbGpPWpGaD
Simvastatin—CYP3A4—Metabolism—CYP19A1—esophageal cancer	3.51e-06	2.67e-05	CbGpPWpGaD
Simvastatin—CYP2C8—Metabolism—NOS3—esophageal cancer	3.43e-06	2.61e-05	CbGpPWpGaD
Simvastatin—CYP2C19—Metabolism—CREBBP—esophageal cancer	3.42e-06	2.6e-05	CbGpPWpGaD
Simvastatin—SLCO1B1—Metabolism—PIK3CA—esophageal cancer	3.36e-06	2.55e-05	CbGpPWpGaD
Simvastatin—ABCB1—Metabolism—CREBBP—esophageal cancer	3.33e-06	2.53e-05	CbGpPWpGaD
Simvastatin—CYP3A4—Metabolism—HMOX1—esophageal cancer	3.2e-06	2.43e-05	CbGpPWpGaD
Simvastatin—CYP2D6—Metabolism—CREBBP—esophageal cancer	3.14e-06	2.39e-05	CbGpPWpGaD
Simvastatin—CYP2C8—Metabolism—PTGS2—esophageal cancer	3.13e-06	2.38e-05	CbGpPWpGaD
Simvastatin—CYP2C9—Metabolism—CREBBP—esophageal cancer	3.12e-06	2.37e-05	CbGpPWpGaD
Simvastatin—CYP3A7—Metabolism—PIK3CA—esophageal cancer	3.08e-06	2.34e-05	CbGpPWpGaD
Simvastatin—CYP2B6—Metabolism—EP300—esophageal cancer	3.08e-06	2.34e-05	CbGpPWpGaD
Simvastatin—CYP3A4—Metabolism—ABCB1—esophageal cancer	3.07e-06	2.34e-05	CbGpPWpGaD
Simvastatin—CYP2C19—Metabolism—NOS3—esophageal cancer	3.06e-06	2.33e-05	CbGpPWpGaD
Simvastatin—CYP3A5—Metabolism—EP300—esophageal cancer	3.01e-06	2.29e-05	CbGpPWpGaD
Simvastatin—ABCB1—Metabolism—NOS3—esophageal cancer	2.99e-06	2.27e-05	CbGpPWpGaD
Simvastatin—CYP2D6—Metabolism—NOS3—esophageal cancer	2.81e-06	2.14e-05	CbGpPWpGaD
Simvastatin—CYP2C19—Metabolism—PTGS2—esophageal cancer	2.8e-06	2.13e-05	CbGpPWpGaD
Simvastatin—CYP2C9—Metabolism—NOS3—esophageal cancer	2.79e-06	2.12e-05	CbGpPWpGaD
Simvastatin—ABCB1—Metabolism—PTGS2—esophageal cancer	2.73e-06	2.08e-05	CbGpPWpGaD
Simvastatin—CYP2C8—Metabolism—EP300—esophageal cancer	2.61e-06	1.98e-05	CbGpPWpGaD
Simvastatin—CYP2D6—Metabolism—PTGS2—esophageal cancer	2.57e-06	1.96e-05	CbGpPWpGaD
Simvastatin—CYP2C9—Metabolism—PTGS2—esophageal cancer	2.55e-06	1.94e-05	CbGpPWpGaD
Simvastatin—CYP2C19—Metabolism—EP300—esophageal cancer	2.33e-06	1.77e-05	CbGpPWpGaD
Simvastatin—CYP2B6—Metabolism—PIK3CA—esophageal cancer	2.28e-06	1.73e-05	CbGpPWpGaD
Simvastatin—ABCB1—Metabolism—EP300—esophageal cancer	2.27e-06	1.73e-05	CbGpPWpGaD
Simvastatin—CYP3A5—Metabolism—PIK3CA—esophageal cancer	2.23e-06	1.69e-05	CbGpPWpGaD
Simvastatin—CYP2D6—Metabolism—EP300—esophageal cancer	2.14e-06	1.63e-05	CbGpPWpGaD
Simvastatin—CYP2C9—Metabolism—EP300—esophageal cancer	2.12e-06	1.61e-05	CbGpPWpGaD
Simvastatin—CYP3A4—Metabolism—CREBBP—esophageal cancer	2.05e-06	1.56e-05	CbGpPWpGaD
Simvastatin—CYP2C8—Metabolism—PIK3CA—esophageal cancer	1.93e-06	1.47e-05	CbGpPWpGaD
Simvastatin—CYP3A4—Metabolism—NOS3—esophageal cancer	1.84e-06	1.4e-05	CbGpPWpGaD
Simvastatin—CYP2C19—Metabolism—PIK3CA—esophageal cancer	1.72e-06	1.31e-05	CbGpPWpGaD
Simvastatin—CYP3A4—Metabolism—PTGS2—esophageal cancer	1.68e-06	1.28e-05	CbGpPWpGaD
Simvastatin—ABCB1—Metabolism—PIK3CA—esophageal cancer	1.68e-06	1.28e-05	CbGpPWpGaD
Simvastatin—CYP2D6—Metabolism—PIK3CA—esophageal cancer	1.58e-06	1.2e-05	CbGpPWpGaD
Simvastatin—CYP2C9—Metabolism—PIK3CA—esophageal cancer	1.57e-06	1.19e-05	CbGpPWpGaD
Simvastatin—CYP3A4—Metabolism—EP300—esophageal cancer	1.4e-06	1.06e-05	CbGpPWpGaD
Simvastatin—CYP3A4—Metabolism—PIK3CA—esophageal cancer	1.04e-06	7.87e-06	CbGpPWpGaD
